Relay Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
RLAY on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
399 Binney Street, 2 Nd Floor, Cambridge, MA

Insiders trading volume in the past year

Relay Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sanjiv Patel President and CEO, Director $5.35M -$3.48M -39.4% Jul 9, 2025
Donald A. Bergstrom President, R&D $2.03M -$593K -22.6% Jul 28, 2025
Peter Rahmer Chief Corporate Develpment Officer $1.39M -$662K -32.2% Jul 28, 2025
Brian Adams Chief Legal Officer $1.37M -$377K -21.6% Jul 28, 2025
Thomas Catinazzo Chief Financial Officer $1.23M -$491K -28.5% Jul 28, 2025
Jami Rubin Director $339K Jun 6, 2025
Andy Porter Chief Administrative Officer $272K Oct 28, 2022
Douglas S. Ingram Director Jun 6, 2025
Linda A. Hill Director Jun 6, 2025
Claire Mazumdar Director Jun 9, 2025
Laura Shawver Director Jun 3, 2024
Alexis Borisy Director Jun 6, 2025
Mark Murcko Director Jun 6, 2025
Sekar Kathiresan Director Jun 6, 2025

Recent Insider Transactions by Companies or Individuals for Relay Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.